CCL17 and idiopathic pulmonary fibrosis: Based on peripheral blood proteomic profiling data of IPF biomarkers in the multicenter IPF-PRO Registry, circulating levels of CCL17 and CCL22 are higher in the IPF patients than in controls [71].